Novavax to Host an Analyst and Investor Meeting with Webcast
Sep 23, 2014 from 9:00 AM to 11:00 AM EDT
Senior management will conduct a series of presentations to update analysts and investors as to the company's recombinant nanoparticle vaccine technology, its RSV F-protein vaccine candidate and its influenza vaccine candidates.